Glucagon liquid - Latitude Pharmaceuticals

Drug Profile

Glucagon liquid - Latitude Pharmaceuticals

Alternative Names: Glucagon nanoemulsion - Latitude Pharmaceuticals; Nano-G; Stable liquid glucagon formulation - Latitude Pharmaceuticals

Latest Information Update: 03 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Latitude Pharmaceuticals
  • Class Antihypoglycaemics; Pancreatic hormones
  • Mechanism of Action Glucagon receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Hypoglycaemia

Most Recent Events

  • 03 Apr 2012 Latitude Pharmaceuticals stable glucagon product (Nano-G) is available for licensing as of 03 Apr 2012.
  • 03 Apr 2012 Preclinical trials in Hypoglycaemia in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top